Literature DB >> 6089651

Direct membrane-damaging effect of ketoconazole and tioconazole on Candida albicans demonstrated by bioluminescent assay of ATP.

S Anséhn, L Nilsson.   

Abstract

Bioluminescent assays of fungal ATP in cultures of Candida albicans exposed to tioconazole and ketoconazole demonstrated that intracellular ATP levels were directly related to cell viability. At high concentrations of drug, a fungicidal effect was indicated by a very rapid and heavy leakage of ATP and a simultaneous, dramatic decrease in intracellular ATP. This leakage was due to direct membrane damage, which was less pronounced after exposure to ketoconazole than to tioconazole. After exposure to lower imidazole concentrations, intracellular ATP indicated growth inhibition without significant leakage of ATP. These findings support the hypothesis that imidazole antifungal agents basically act in the same manner but at different concentrations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6089651      PMCID: PMC179909          DOI: 10.1128/AAC.26.1.22

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  New rapid bioassay of gentamicin based on luciferase assay of extracellular ATP in bacterial cultures.

Authors:  L Nilsson
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

2.  Modern aspects of testing azole antifungals.

Authors:  I Haller
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

3.  Heterogeneity of action of mechanisms among antimycotic imidazoles.

Authors:  I J Sud; D S Feingold
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

4.  Effects of pH on the activity of ketoconazole against Candida albicans.

Authors:  H Minagawa; K Kitaura; N Nakamizo
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

5.  Mechanisms of action of the antimycotic imidazoles.

Authors:  I J Sud; D S Feingold
Journal:  J Invest Dermatol       Date:  1981-06       Impact factor: 8.551

6.  Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

7.  Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester.

Authors:  P D Hoeprich; A C Huston
Journal:  J Infect Dis       Date:  1976-10       Impact factor: 5.226

8.  Primary site of action of ketoconazole on Candida albicans.

Authors:  J Uno; M L Shigematsu; T Arai
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

9.  In vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Appl Microbiol       Date:  1969-06

10.  Comparison of miconazole- and ketoconazole-induced release of K+ from Candida species.

Authors:  W H Beggs
Journal:  J Antimicrob Chemother       Date:  1983-04       Impact factor: 5.790

View more
  17 in total

1.  Is it morphologic type or physiologic state that governs susceptibility of Candida albicans to clotrimazole kill?

Authors:  W H Beggs; I R LaSota; C E Hughes
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

Review 2.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 3.  Use of amphotericin B with azole antifungal drugs: what are we doing?

Authors:  A M Sugar
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

4.  Real-Time Imaging of the Azole Class of Antifungal Drugs in Live Candida Cells.

Authors:  Raphael I Benhamou; Maayan Bibi; Kfir B Steinbuch; Hamutal Engel; Maayan Levin; Yael Roichman; Judith Berman; Micha Fridman
Journal:  ACS Chem Biol       Date:  2017-05-12       Impact factor: 5.100

5.  Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans.

Authors:  S E Koshlukova; M W Araujo; D Baev; M Edgerton
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect.

Authors:  Daisuke Kobayashi; Kei Kondo; Nobuyuki Uehara; Seiko Otokozawa; Naoki Tsuji; Atsuhito Yagihashi; Naoki Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

7.  Entry of ketoconazole into Candida albicans.

Authors:  P Boiron; E Drouhet; B Dupont; L Improvisi
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

8.  Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi.

Authors:  C Borelli; M Schaller; M Niewerth; K Nocker; B Baasner; D Berg; R Tiemann; K Tietjen; B Fugmann; S Lang-Fugmann; H C Korting
Journal:  Chemotherapy       Date:  2008-06-30       Impact factor: 2.544

9.  Differentially expressed proteins in derivatives of Candida albicans displaying a stable histatin 3-resistant phenotype.

Authors:  Deirdre H Fitzgerald-Hughes; David C Coleman; Brian C O'Connell
Journal:  Antimicrob Agents Chemother       Date:  2007-05-07       Impact factor: 5.191

Review 10.  Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses.

Authors:  S P Clissold; R C Heel
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.